Biosound releases upgrade for AU4

Article

Ultrasound vendor Biosound of Indianapolis will unveil a majorproduct upgrade developed by its parent, Esaote Biomedica of Italy.Introduced as an upgrade for Biosound's high-performance AU4 platform,Advanced Contrast Technology (ACT) incorporates

Ultrasound vendor Biosound of Indianapolis will unveil a majorproduct upgrade developed by its parent, Esaote Biomedica of Italy.Introduced as an upgrade for Biosound's high-performance AU4 platform,Advanced Contrast Technology (ACT) incorporates interactive managementof apodization and dynamic control of beam amplitude to improvecontrast resolution. ACT also provides time-wait processing thatadapts the beam velocity to different tissue impedances. An inexpensiveblack-and-white, color-upgradable version of Biosound's AU3 systemwill also be shown.

Recent Videos
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Related Content
© 2025 MJH Life Sciences

All rights reserved.